Innoviva, Inc. Common Stock (INVA) is a publicly traded Healthcare sector company. As of May 21, 2026, INVA trades at $22.62 with a market cap of $1.61B and a P/E ratio of 3.12. INVA moved +2.35% today. Year to date, INVA is +11.03%; over the trailing twelve months it is +18.42%. Its 52-week range spans $16.52 to $25.15. Analyst consensus is buy with an average price target of $34.60. Rallies surfaces INVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Innoviva, Inc. Common Stock (INVA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INVA moved +2.35% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $22.62 |
| Market Cap | $1.61B |
| P/E Ratio | 3.12 |
| EPS | $7.20 |
| Dividend Yield | 0.25% |
| 52-Week High | $25.15 |
| 52-Week Low | $16.52 |
| Volume | 24 |
| Avg Volume | 0 |
| Revenue (TTM) | $420.69M |
| Net Income | $504.34M |
| Gross Margin | 73.73% |
5 analysts cover INVA: 0 strong buy, 4 buy, 0 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $34.60.